Latest filing published 20 Sept 2021 for Magenta Therapeutics, Inc., €33k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David Wayne Nichols: trading record in brief
This profile gathers the share dealings of David Wayne Nichols in Dianthus Therapeutics, Inc. /DE/, where the filings describe the role as senior executive. We count 2 filings; the first trade dates from 14 September 2021 and the latest from 16 September 2021.
Every open-market trade on record is a sale: 1 sale worth €33k. Outside the open market, there are 1 share grant.
The record was last updated on 20 September 2021 with an open-market sale (€33k) in Dianthus Therapeutics, Inc. /DE/. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Wayne Nichols
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,694 shares@ US$6.73100.0% of flowCommon StockSEC:0000899243-21-036595:0
- 20,000 shares0Common StockSEC:0000899243-21-036333:0
2 of 2 declarations
